{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:11:40Z","timestamp":1790435500290,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jid.2018.01.039","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T13:19:16Z","timestamp":1519996756000},"page":"1726-1735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United\u00a0Kingdom"],"prefix":"10.1016","volume":"138","author":[{"given":"Junko","family":"Takeshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ogdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.01.039_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jid.2018.01.039_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"10.1016\/j.jid.2018.01.039_bib4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archdermatol.2012.1401","article-title":"Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis","volume":"148","author":"Azfar","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"},{"key":"10.1016\/j.jid.2018.01.039_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2018.01.039_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/377435a0","article-title":"Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor","volume":"377","author":"Cundell","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jid.2018.01.039_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK general practice research database for pharmacoepidemiology","volume":"45","author":"Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2018.01.039_bib9","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2018.01.039_bib11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study","volume":"141","author":"Gelfand","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased beta-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2018.01.039_bib13","doi-asserted-by":"crossref","first-page":"e116077","DOI":"10.1371\/journal.pone.0116077","article-title":"Psoriasis and the risk of pneumonia: a population-based study","volume":"9","author":"Kao","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jid.2018.01.039_bib14","first-page":"91","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older\u2014United States, 2015","volume":"64","author":"Kim","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jid.2018.01.039_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2018.01.039_bib18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/514125","article-title":"Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms","volume":"176","author":"Mason","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2018.01.039_bib19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jid.2018.01.039_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pds.3207","article-title":"Accuracy of pneumonia hospital admissions in a primary care electronic medical record database","volume":"21","author":"Meropol","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2018.01.039_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/pds.3677","article-title":"Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network","volume":"23","author":"Ogdie","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2018.01.039_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jid.2018.01.039_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jclinepi.2008.06.006","article-title":"Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients","volume":"62","author":"Patkar","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jid.2018.01.039_bib24","first-page":"602","article-title":"Validity of The Health Improvement Network (THIN) for the study of psoriasis","volume":"164","author":"Seminara","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.15665","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017","volume":"177","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib26","first-page":"93","article-title":"Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years\u2014United States, 2015","volume":"64","author":"Strikas","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jid.2018.01.039_bib27","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Suarez-Farinas","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.01.039_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2010.08.036","article-title":"Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort","volume":"65","author":"Wakkee","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib30","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study","volume":"347","author":"Wan","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2018.01.039_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/153.2.202","article-title":"Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection","volume":"153","author":"White","year":"1986","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2018.01.039_bib32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2013.06.046","article-title":"From the Medical Board of the National Psoriasis Foundation: vaccination in adult patients on systemic therapy for psoriasis","volume":"69","author":"Wine-Lee","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.01.039_bib33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1164\/rccm.200506-888OC","article-title":"Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia","volume":"172","author":"Yende","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jid.2018.01.039_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18301532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18301532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:11:27Z","timestamp":1758301887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18301532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022202X18301532"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.01.039","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United\u00a0Kingdom","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}